We are monitoring the impact of COVID-19 on Europe African Horse Sickness Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5486
Share on
Share on

Europe African Horse Sickness Treatment Market Research Report - Segmented By Clinical Form, Diagnosis & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, Share, Trends, Growth, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 5486
Pages: 145

Europe African Horse Sickness Treatment Market Size & Growth (2019 – 2024):

According to the report, the Europe African Horse Sickness Treatment Market is valued at USD xx Billion in 2019 and is projected to reach USD xx Billion by 2024, growing at a CAGR of xx.x% during the forecast period 2019-2024.

African horse sickness is caused by a virus of the genus Orbivirus belonging to the family Reoviridae which is highly infectious and deadly disease and it commonly affects horses, mules, and donkeys. This virus is commonly known as the African Horse Sickness Virus.  It is not directly contagious, but is known to be spread by insect vectors and can be caused by any of the nine serotypes of this virus. This disease has a mortality rate of 95% in horses, which are most susceptible to the disease, while mules and donkeys are less likely to African horse sickness disease.

Good vaccination program is the best preventive method for African horse sickness treatment. In addition, good nutritional program and regular deworming which forms an integral part of horse health. The affected horses are slaughtered usually, where the uninfected horses are vaccinated against the virus. These type of prevention programs are efficient and cost-effective ways to prevent common infectious diseases in a horse.

Presence of guidelines and standard operating procedures for African horse sickness disease, rising in research and development programs for various preventive vaccines, increasing awareness regarding vaccination of horses, rising healthcare infrastructure, increase in disposable income and technology innovations in the medical sector are driving the growth of the market. However, the multivalent vaccine which does not guarantee that the horses are completely protected from the African horse sickness and high vaccine cost is hampering the growth of the market.

Europe African Horse Sickness Treatment Market has been segmented and sub-segmented into the following categories

  • By Clinical Form: Dikkop or Cardiac form, Dunkop or Pulmonary form, horse sickness fever, mixed form.
  • By Diagnosis: preventive treatment (vaccines and diagnostic tests & Serological Tests).
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

On the basis of region, the market in this region is projected to grow strongly during the forecast period due to various factors such as growing awareness and favourable reimbursement policies.

Promising Companies leading the Europe African Horse Sickness Treatment Market Profiled in the Report are Veterinary Serum and Vaccine Research Institute and Onderstepoort Biological Products SOC Ltd.

1. Introduction     

               1.1 Market Definition                    

               1.2 Study Deliverables                   

               1.3 Base Currency, Base Year and Forecast Periods

               1.4 General Study Assumptions                  

2. Research Methodology               

               2.1 Introduction               

               2.2 Research Phases                      

   2.2.1 Secondary Research            

   2.2.2 Primary Research  

   2.2.3 Econometric Modelling      

   2.2.4 Expert Validation   

               2.3 Analysis Design                         

               2.4 Study Timeline                          

3. Overview          

               3.1 Executive Summary                 

               3.2 Key Inferences                          

               3.3 Epidemiology  

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

               4.1 Market Drivers                         

               4.2 Market Restraints                    

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market                 

5. Market Segmentation   

               5.1 Clinical forms 

   5.1.1 Introduction           

   5.1.2 Dikkop or Cardiac form       

   5.1.3 Dunkop or Pulmonary form

   5.1.4 Horse sickness fever            

   5.1.5 Mixed form             

   5.1.6 Y-o-Y Growth Analysis, By Clinical forms      

   5.1.7 Market Attractiveness Analysis, By Clinical forms      

   5.1.8 Market Share Analysis, By Clinical forms      

               5.2 Diagnosis                    

   5.2.1 Introduction           

   5.2.2 Prevention treatment          

                  5.2.2.1 Vaccines

   5.2.3 Diagnostic tests     

                  5.2.3.1 Laboratory tests for viral antigens

                  5.2.3.2 Serological tests

   5.2.4 Y-o-Y Growth Analysis, By Diagnosis             

   5.2.5 Market Attractiveness Analysis, By Diagnosis             

   5.2.6 Market Share Analysis, By Diagnosis              

6. Geographical Analysis   

               6.1 Introduction               

   6.1.1 Regional Trends     

   6.1.2 Impact Analysis      

   6.1.3 Y-o-Y Growth Analysis         

                  6.1.3.1 By Geographical Area

                  6.1.3.2 By Clinical forms

                  6.1.3.3 By Diagnosis

   6.1.4  Market Attractiveness Analysis       

                  6.1.4.1 By Geographical Area

                  6.1.4.2 By Clinical forms

                  6.1.4.3 By Diagnosis

   6.1.5  Market Share Analysis        

                  6.1.5.1 By Geographical Area

                  6.1.5.2 By Clinical forms

                  6.1.5.3 By Diagnosis

               6.2 U.K                

               6.3 Spain 

               6.4 Germany                     

               6.5 Italy  

               6.6 France    

               6.7 Rest of Europe                     

7. Strategic Analysis           

               7.1 PESTLE analysis                        

   7.1.1 Political    

   7.1.2 Economic 

   7.1.3 Social        

   7.1.4 Technological        

   7.1.5 Legal         

   7.1.6 Environmental       

               7.2 Porter’s Five analysis              

   7.2.1 Bargaining Power of Suppliers         

   7.2.2 Bargaining Power of Consumers     

   7.2.3 Threat of New Entrants      

   7.2.4 Threat of Substitute Products and Services  

   7.2.5 Competitive Rivalry within the Industry        

8. Market Leaders' Analysis             

               8.1 Veterinary Serum and Vaccine Research Institute                        

   8.1.1 Overview  

   8.1.2 Product Analysis    

   8.1.3 Financial analysis   

   8.1.4 Recent Developments         

   8.1.5 SWOT analysis       

   8.1.6 Analyst View           

               8.2 Onderstepoort Biological Products SOC                          

9. Competitive Landscape               

               9.1 Market share analysis 

               9.2 Merger and Acquisition Analysis                         

               9.3 Agreements, Collaborations, and Joint Ventures

               9.4 New Product Launches                          

10. Market Outlook and Investment Opportunities                

Appendix               

               a) List of Tables                

               b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe African Horse Sickness Treatment Market By Clinical forms, From 2019-2024 ( USD Billion )
  2. Europe Dikkop or Cardiac form Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Dunkop or Pulmonary form Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Horse sickness fever Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Mixed form Market By Region, From 2019-2024 ( USD Billion )
  6. Europe African Horse Sickness Treatment Market By Diagnosis, From 2019-2024 ( USD Billion )
  7. Europe Prevention treatment  Market By Region, From 2019-2024 ( USD Billion )
  8. Europe Diagnostic tests  Market By Region, From 2019-2024 ( USD Billion )
  9. U.K. African Horse Sickness Treatment Market By Clinical forms , From 2019-2024 ( USD Billion )
  10. U.K. African Horse Sickness Treatment Market By Diagnosis, From 2019-2024 ( USD Billion )
  11. Germany African Horse Sickness Treatment Market By Clinical forms , From 2019-2024 ( USD Billion )
  12. Germany African Horse Sickness Treatment Market By Diagnosis, From 2019-2024 ( USD Billion )
  13. France African Horse Sickness Treatment Market By Clinical forms , From 2019-2024 ( USD Billion )
  14. France African Horse Sickness Treatment Market By Diagnosis, From 2019-2024 ( USD Billion )
  15. Italy African Horse Sickness Treatment Market By Clinical forms , From 2019-2024 ( USD Billion )
  16. Italy African Horse Sickness Treatment Market By Diagnosis, From 2019-2024 ( USD Billion )
  17. Spain African Horse Sickness Treatment Market By Clinical forms , From 2019-2024 ( USD Billion )
  18. Spain African Horse Sickness Treatment Market By Diagnosis, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample